12/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

12/2024

Dec 13, 2024, 16:21 | Blog
Francisco J. Esteva: Kicking off SABCS24 with the amazing breast cancer team from Northwell Cancer Institute
Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital,…
Dec 13, 2024, 16:16 | Blog
ESMO - Neoadjuvant immunotherapy sets a new standard in stage III melanoma
ESMO shared on LinkedIn: "More than 40% of patients with resectable stage III melanoma experience disease…
Dec 13, 2024, 16:10 | Insight
A Paradigm Shift in Tumor Immunology - Cancer Research
Cancer Research shared a recent article on X: "A Paradigm Shift in Tumor Immunology: Th17…
Dec 13, 2024, 16:09 | Blog
Guilherme Nader Marta: Biomarker analyses of KN-522 shows most markers were prognostic but not predictive
Guilherme Nader Marta, Clinical Fellow at Dana-Farber Cancer Institute, shared a post on X: "Biomarker…
Dec 13, 2024, 16:02 | Blog
Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma
Brandon Sheffield, Diagnostic and Molecular Pathologist at William Osler Health System, shared on LinkedIn: "Great…
Dec 13, 2024, 16:01 | Blog
Pancreatic cancer is one of the leading causes of cancer-related death in NSW - Cancer Institute NSW
Cancer Institute NSW shared on LinkedIn: “Pancreatic cancer is one of the leading causes of…
Dec 13, 2024, 15:59 | Insight
Arndt Vogel: Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC
Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and…
Dec 13, 2024, 15:52 | Blog
SOLTI-2103 VALENTINE Trial: Phase II Trial of Neoadjuvant Patritumab Deruxtecan vs. Chemotherapy for High-Risk HR+/HER2- Early Breast Cancer
Neoadjuvant treatment for high-risk HR+/HER2- early breast cancer (EBC) remains challenging, with recurrence risks persisting…
Dec 13, 2024, 15:51 | Insight
Insights from SABCS 2024 part 2
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…
Dec 13, 2024, 15:45 | Insight
MD Anderson Cancer Center and AmMax Bio announced agreement to develop AMB-066 monoclonal antibody therapy
The University of Texas MD Anderson Cancer Center and AmMax Bio recently announced a worldwide…
All: 2612 Posts: 1501 - 1510
Special Coverage